About this episode
Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- AstraZeneca and Ionis Pharmaceuticals Inc.’s gene silencer drug Wainua failed to help prevent heart problems in patients with a rare and potentially fatal disease of the organ. AstraZeneca’s shares slumped.
- Schott Pharma shares jump by a record 22% after the company improved its guidance for the full year, prompting an upgrade at RBC Capital Markets. The stock is trading at its highest level since October.
- Bulgaria’s government may not be able to secure funding for joint project with Rheinmetall for NATO-standard shell, gunpowder plant, Mediapool news website reports, citing Economy Minister Alexander Pulev.
See omnystudio.com/listener for privacy information.
Get every episode summarized
Each time Stock Movers publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Stock Movers
Weekly Roundup: Skyworks Surges, Lululemon Falls, Cooper Drops
Stock Movers
Closing Bell: HPE Rallies, Dell Gains, Oracle Slips
Stock Movers
Oracle After Earnings, Microsoft Rallies, Adobe Disappoints
Stock Movers
Oracle Gains; Microsoft Plans Data Center Push; Adobe Forecast Misses Views
Stock Movers